OS Therapies IncorporatedOSTXNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank20
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-13.35M
↑ 97% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-407.83M
Historical baseline
PeriodValueYoY Change
TTM$-13.35M-83.3%
2024$-7.28M-142.2%
2023$-3.01M+20.7%
2022$-3.79M+14.1%
2021$-4.41M+99.8%
2020$-2.42B-